[Adverse effects and safety of antimicrobial agents-neurotoxicities].
Hori
Seiji
S
Department of Pharmacology(I), The Jikei University School of Medicine.
D000617:Aminoglycosides / Q000009:adverse effects; D000818:Animals; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D002493:Central Nervous System Diseases / Q000139:chemically induced*; D004347:Drug Interactions; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects; D020511:Neuromuscular Junction Diseases / Q000139:chemically induced; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced*; D015363:Quinolones / Q000009:adverse effects; D013754:Tetracyclines / Q000009:adverse effects; D047090:beta-Lactams / Q000009:adverse effects
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D015363:Quinolones; D013754:Tetracyclines; D047090:beta-Lactams; D007538:Isoniazid